Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PREMIER Biosoft Announce Successful Delivery of OligoArchitect™ Online v4.0 to Sigma-Aldrich

Published: Thursday, September 05, 2013
Last Updated: Thursday, September 05, 2013
Bookmark and Share
As a part of its contract software development services, PREMIER Biosoft has delivered OligoArchitect™ Online v4.0 to Sigma Life Science.

PREMIER Biosoft, as a part of its contract software development services, has delivered OligoArchitect™ Online v4.0 to Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich. Sigma-Aldrich, with operations in over 40 countries, is a life science and high technology company. Its chemical and biochemical products are used in scientific research and as key components in high technology manufacturing.

This release of version 4.0  of OligoArchitect™ Online offers added LNA® base substitution in Dual-Labeled Probe, Molecular Beacon and LightCycler® Probe design modules. 

"By introducing LNA design capabilities into OligoArchitect Online, a wide range of customers can now gain access to this chemistry. PREMIER Biosoft is now our trusted vendor, after demonstrating exemplary delivery of former versions of OligoArchitect and OligoEvaluator™," said Tom Russell, Product Manager at Sigma Life Science.

"After the successful launch of version 3.0 of OligoArchitect, Sigma further raised the bar by requesting support for LNA design. Our goal is to offer Sigma customers the best possible user experience and robust design algorithms," said Arun Apte, CEO, PREMIER Biosoft.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PREMIER Biosoft Announces Collaboration with University of Utah
Formal collaboration to advance metabolomics and lipidomics research.
Friday, August 07, 2015
PREMIER Biosoft Wins CIOReview's "Company of the Year" Award
"Company of the Year" award for the year 2014 in the life science category.
Thursday, February 19, 2015
PREMIER Biosoft Launches SimMet for Analysis of MS Metabolite data
SimMet is a high throughput, intuitive informatics tool for qualitative and quantitative analysis of mass spectrometry metabolite data.
Tuesday, May 27, 2014
PREMIER Biosoft and JEOL Enter Agreement
The co-marketing agreement aims to advance research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology.
Thursday, June 06, 2013
PREMIER Biosoft Acquires ProteoIQ
Company adds strength to its mass spectrometry product portfolio with the acquisition of ProteoIQ from NuSep, Australia.
Tuesday, March 12, 2013
Premier Biosoft and MRC-Holland Form Alliance
The alliance will help MLPA® users design custom oligos for genes that do not have kits available.
Monday, October 30, 2006
Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Changing the Biological Data Visualisation World
Scientists at TGAC, alongside European partners, have created a cutting-edge, open source community for the life sciences.
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!